Ulicny K S, Goldberg S J, Harper W J, Korelitz J L, Podore P C, Fegelman R H
Department of Surgery, Jewish Hospital of Cincinnati, Ohio 45229.
Surg Gynecol Obstet. 1988 Jun;166(6):535-40.
A retrospective review of our initial experience with the Garren-Edwards Gastric Bubble (American Edwards Laboratories) was undertaken to study its surgical complications. Between 22 February and 30 August 1986, 250 patients had 275 gastric bubbles endoscopically inserted as an adjuvant treatment for morbid obesity. Profiles of the first 104 patients revealed a mean weight of 113.0 kilograms (74 per cent above ideal body weight) and a mean weight loss of 10.1 kilograms (0.76 kilogram per week) followed by a gain of 0.48 kilogram from the period of peak weight loss at 13.7 weeks to removal at 19.4 weeks. Thirty-three per cent had endoscopic removal and the remainder passed per rectum. Ninety-two had undergone previous abdominal operation. Five instances of obstruction of the upper part of the gastrointestinal tract (mean 18.3 weeks after insertion) required three operative removals, one endoscopic retrieval from the second portion of the duodenum and one hypaque small intestinal series with oral mineral oil to induce spontaneous passage. Four of the five patients had prior abdominal operations--cholecystectomy in one instance, appendectomy in one, cholecystectomy and appendectomy in one and exploratory laparotomy for multiple stab wounds in one. One (multiple stab wounds) had adhesions at the point of the obstruction. The patient who underwent endoscopic retrieval had premature deflation at 6.7 weeks presumably due to a defective bubble. The weight gain after peak weight loss at 13.7 weeks likely represents spontaneous bubble deflation. Prior abdominal surgical treatment appears to be a significant risk factor for the development of obstruction after bubble deflation. In addition, two of five patients have been lost to follow-up study after insertion. Proper patient selection and careful monitoring may be crucial in reducing the morbidity associated with the Garren-Edwards Gastric Bubble.
对我们使用加伦 - 爱德华兹胃泡(美国爱德华兹实验室)的初步经验进行了回顾性研究,以探讨其手术并发症。1986年2月22日至8月30日期间,250例患者通过内镜插入了275个胃泡,作为病态肥胖的辅助治疗。前104例患者的资料显示,平均体重为113.0千克(比理想体重高74%),平均体重减轻10.1千克(每周0.76千克),随后从体重减轻高峰期的13.7周至取出时的19.4周体重又增加了0.48千克。33%的胃泡通过内镜取出,其余经直肠排出。92例患者曾接受过腹部手术。发生了5例上消化道梗阻(平均在插入后18.3周),其中3例需要手术取出,1例通过内镜从十二指肠第二部取出,1例通过泛影葡胺小肠造影并口服矿物油促使自行排出。5例患者中有4例曾接受过腹部手术——1例为胆囊切除术,1例为阑尾切除术,1例为胆囊切除术和阑尾切除术,1例因多处刺伤接受过剖腹探查术。1例(多处刺伤)在梗阻部位有粘连。接受内镜取出的患者在6.7周时胃泡过早瘪陷,可能是由于胃泡有缺陷。在体重减轻高峰期13.7周后的体重增加可能代表胃泡自行瘪陷。既往腹部手术治疗似乎是胃泡瘪陷后发生梗阻的一个重要危险因素。此外,5例患者中有2例在插入胃泡后失访。正确选择患者并仔细监测对于降低与加伦 - 爱德华兹胃泡相关的发病率可能至关重要。